edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: MindMaze Therapeutics
MindMaze Therapeutics (previously Relief Therapeutics) is a Swiss med-tech company advancing and commercialising a proprietary driven platform focused on neurotherapeutic solutions to treat neurological diseases (such as stroke and TBI), integrating software-based treatments with innovative technology, data and AI to improve patient outcomes.
MindMaze Therapeutics — 2 videos in collection
In this two-part interview, Zach Henderson, CEO of MindMaze Therapeutics, first discusses how the company’s proprietary digital neurotherapeutics solutions may improve care and outcomes following neurological events such as stroke and traumatic brain or spinal cord injury. He explains how patients with these conditions often do not receive the intensity of rehabilitation therapy necessary to maximize their recovery, and how MindMaze’s comprehensive suite of solutions spanning the continuum of care from acute inpatient facilities to at-home rehabilitation, provides an effective and validated solution. In the second part of the interview, Henderson provides details on the company’s advancing commercialisation strategy in the US and major markets, with prospects for further expansion through partnerships with leading industry participants.
Get access to the very latest content matched to your personal investment style.